{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:46:44Z","timestamp":1790844404973,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[1994,7]]},"DOI":"10.1007\/bf01745244","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T17:04:49Z","timestamp":1118768689000},"page":"S5-S9","source":"Crossref","is-referenced-by-count":20,"title":["Beta-lactamases: Current situation and clinical importance"],"prefix":"10.1007","volume":"20","author":[{"given":"J.","family":"Garau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01745244_CR1","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1991.00400050040010","volume":"151","author":"LA Dever","year":"1991","unstructured":"Dever LA, Dermody TS (1991) Mechanisms of bacterial resistance to antibiotics. Arch Intern Med 151:886\u2013895","journal-title":"Arch Intern Med"},{"key":"BF01745244_CR2","first-page":"937","volume":"43","author":"A Molavi","year":"1991","unstructured":"Molavi A (1991) Cephalosporins: rationale for clinical use. AFP 43:937\u2013948","journal-title":"AFP"},{"key":"BF01745244_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/29.5.593","volume":"29","author":"C Roy","year":"1992","unstructured":"Roy C, Teruel D, Reig R, Hermida M, Teixell M (1992) \u03b2-lactamases and susceptibility phenotypes to \u03b2-lactam antibiotics inEscherichia coli strains. J Antimicrob Chemother 29:593\u2013594","journal-title":"J Antimicrob Chemother"},{"key":"BF01745244_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01641355","volume":"11","author":"H Knothe","year":"1983","unstructured":"Knothe H, Shah P, Krem\u00e9ry V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates ofKlebsiella pneumoniae andSerratia marcescens. Infection 11:315\u2013317","journal-title":"Infection"},{"key":"BF01745244_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.33.3.259","volume":"33","author":"K Bush","year":"1989","unstructured":"Bush K (1989) Characterization of \u03b2-lactamases. Antimicrob Agents Chemother 33:259\u2013263","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01745244_CR6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/AAC.33.8.1131","volume":"33","author":"A Philippon","year":"1989","unstructured":"Philippon A, Labia R, Jacoby G (1989) Extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother 33:1131\u20131136","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01745244_CR7","unstructured":"Martinez-Beltran J, Canton R, Loza E et al (1990) Resistencia a aminotiazol cefalosporinas y monobactams. Nuevas betalactamasas plasmidicas de amplio espectro detectades en el Hospital Ramon y Cajal. Abstract no. c 6\/9, IV Congreso Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiologia Clinica, Madrid, Spain"},{"key":"BF01745244_CR8","doi-asserted-by":"crossref","unstructured":"Goldstein FN, Pean Y, Rosato A, Vigil Roc Study Group (1992) Prevalence of extended-spectrum \u03b2-lactamases in ceftriaxone-resistant Enterobacteriaceae isolated during a multicentric study. Abstract no. 126, 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, California, USA","DOI":"10.1093\/jac\/32.4.595"},{"key":"BF01745244_CR9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.35.9.1697","volume":"35","author":"GA Jacoby","year":"1991","unstructured":"Jacoby GA, Medeiros AA (1991) More extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother 35:1697\u20131704","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01745244_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/AAC.35.1.147","volume":"35","author":"M Watanabe","year":"1991","unstructured":"Watanabe M, Iyobe S, Inoue M, Mitsuhashi S (1991) Transferable imipenem resistance inPseudomonas aeruginosa. Antimicrob Agents Chemother 35:147\u2013151","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01745244_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-2911(08)60376-8","volume":"9","author":"MH Richmond","year":"1973","unstructured":"Richmond MH, Sykes RB (1973) The \u03b2-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol 9:31\u201388","journal-title":"Adv Microb Physiol"},{"key":"BF01745244_CR12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/clinids\/10.4.830","volume":"10","author":"WE Sanders","year":"1988","unstructured":"Sanders WE, Sanders CC (1988) Inducible \u03b2-lactamases: clinical and epidemiological implications for use of newer cephalosporins. Rev Infect Dis 10:830\u2013838","journal-title":"Rev Infect Dis"},{"key":"BF01745244_CR13","first-page":"9","volume":"11","author":"JM Nogueira","year":"1990","unstructured":"Nogueira JM, Palomares JC, Vazquez JA (1990) Epidemiologia del gonococo en Espa\u00f1a. Enf Trans Sex 11:9\u201315","journal-title":"Enf Trans Sex"},{"key":"BF01745244_CR14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF01964130","volume":"8","author":"DV Fontanals","year":"1989","unstructured":"Fontanals DV, Pineda V, Pons I, Rojo JC (1989) Penicillin-resistant, beta-lactamase producingNeisseria meningitidis in Spain. Eur J Clin Microbial Infect Dis 8:90\u201391","journal-title":"Eur J Clin Microbial Infect Dis"},{"key":"BF01745244_CR15","unstructured":"Bauerfeind A, Mangold P, Schweighart S et al (1992) Molecular analysis of a transferable cephamycinase inKlebsiella pneumonia. Abstract no. 1268, 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, California, USA"},{"key":"BF01745244_CR16","unstructured":"Jara F, Armengol R, B\u00e1quena F, Dalmau D, Sierra M, Garau J (1990) BGN productores de betalactamasa cromos\u00f3mica clase. 1. Su importancia en la sepsis nosocomial. Abstract C2\/3, IV Congreso de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiologia Clinica, Madrid, Spain"},{"key":"BF01745244_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00272399","volume":"11","author":"T Mall","year":"1985","unstructured":"Mall T, Follath F, Salfinger M, Ritz R, Reber H (1985) Moxalactam in nosocomial infections withSerratia marcescens. Intensive Care Med 11:179\u2013183","journal-title":"Intensive Care Med"},{"key":"BF01745244_CR18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archpedi.1985.02140130024022","volume":"139","author":"CS Bryan","year":"1985","unstructured":"Bryan CS, John JF, Sharada PM, Austin TI (1985) Gentamicin vs cefotaxime for therapy of neonatal sepsis. Am J Dis Child 139: 1086\u20131089","journal-title":"Am J Dis Child"},{"key":"BF01745244_CR19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02013108","volume":"6","author":"F Follath","year":"1987","unstructured":"Follath F, Costa E, Thommen A, Frei R, Burdeska A, Meyer J (1987) Clinical consequences of development of resistance to third-generation cephalosporins. Eur J Clin Microbiol 6:446\u2013450","journal-title":"Eur J Clin Microbiol"},{"key":"BF01745244_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/19.3.321","volume":"19","author":"PH Chandrasekar","year":"1987","unstructured":"Chandrasekar PH, Crane LR, Bailey EJ (1987) Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection byPseudomonas aeruginosa in non-neutropenic patients. J Antimicrob Chemother 19:321\u2013329","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 3","key":"BF01745244_CR21","doi-asserted-by":"crossref","first-page":"S711","DOI":"10.1093\/clinids\/6.Supplement_3.S711","volume":"6","author":"L Nichols","year":"1984","unstructured":"Nichols L, Gudmundsson S, Maki DG (1984) Experience with cefsulodin therapy of lower respiratory tract infections caused byPseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia. Rev Infect Dis 6 [Suppl 3]:S711-S720","journal-title":"Rev Infect Dis"},{"key":"BF01745244_CR22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/archinte.1981.00340130051014","volume":"141","author":"DJ Winston","year":"1981","unstructured":"Winston DJ, Busuttil RW, Kurtz TO, Young LS (1981) Moxalactam therapy for bacterial infections. Arch Intern Med 141:1607\u20131612","journal-title":"Arch Intern Med"},{"key":"BF01745244_CR23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/00365548609032359","volume":"18","author":"S Bragman","year":"1986","unstructured":"Bragman S, Sage R, Booth L, Noone P (1986) Ceftazidime in the treatment of seriousPseudomonas aeruginosa sepsis. Scand J Infect Dis 18:425\u2013429","journal-title":"Scand J Infect Dis"},{"key":"BF01745244_CR24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/18.5.635","volume":"18","author":"A Paull","year":"1986","unstructured":"Paull A, Morgan JR (1986) Emergence of ceftriaxone-resistant strains ofPseudomonas aeruginosa in cystic fibrosis patients. J Antimicrob Chemother 18:635\u2013639","journal-title":"J Antimicrob Chemother"},{"key":"BF01745244_CR25","first-page":"110","volume":"4","author":"RA Weinstein","year":"1985","unstructured":"Weinstein RA (1985) Occurrence of cefotaxime-resistant enterobacter during therapy of cardiac surgery patients. Chemioterapia 4:110\u2013112","journal-title":"Chemioterapia"},{"key":"BF01745244_CR26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/BF02013110","volume":"6","author":"DL Dworzack","year":"1987","unstructured":"Dworzack DL, Pugsley MP, Sanders CC, Horowitz EA (1987) Emergence of resistance in Gram-negative bacteria during therapy with expanded-spectrum cephalosporins. Eur J Clin Microbiol 6: 456\u2013459","journal-title":"Eur J Clin Microbiol"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01745244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01745244\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01745244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T18:41:39Z","timestamp":1586284899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01745244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":26,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["BF01745244"],"URL":"https:\/\/doi.org\/10.1007\/bf01745244","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}